---
category: news
title: "Cyagen and Neurophth partner to develop gene therapy vectors"
excerpt: "Cyagen and Neurophth Therapeutics have entered a strategic partnership to jointly develop next-generation AAV gene therapy vectors for specific kinds of genetic ophthalmic ailments. According to the deal, Cyagen will leverage its artificial intelligence ..."
publishedDateTime: 2022-11-08T14:58:00Z
originalUrl: "https://www.pharmaceutical-technology.com/news/cyagen-neurophth-gene-therapy/"
webUrl: "https://www.pharmaceutical-technology.com/news/cyagen-neurophth-gene-therapy/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: Pharmaceutical Technology
  domain: pharmaceutical-technology.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/11/gayatri-malhotra-pXO2ceFOrOk-unsplash-1038x778.jpg"
    width: 1038
    height: 778
    isCached: true

secured: "lIXKRBA6pp8btRZ8eq+D9zGof0rs5vFGFVCZAaGTUCute72bsTZTLEwGLgUbRMNanqOLrBIvsFf3yBIz2QzOz3PkfNpwwGFlfXgU+uiqRS3FPlqaDbZJouFpk/OmIPHiqRtUSt7es8ljRj9ZlqeofZk8BVN4a+rwg8tC3AzXhaN3x1BT9GNDtrdccy8HZBHelKtbNECepgX5YKydyRStNxe5aVPkDV6R4GBhCFwJ+mE9zbvuaiulWqVcqaGsbeY41jZHDuR49bUc+CmCZ05404N/QgHx0BIz4EbhCtSiBt/QzYUMPGaxnJcgG59cHv7jhgEk+e11UwNLlEhqgMJrQ2wEV1KvmxdujYVhHvD1uas=;+zIBE+eXM96wOv9q7LJnQw=="
---

